We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDA icon
1576
Idacorp
IDA
$8.2B
$34K ﹤0.01%
314
-278
-47% -$29.7K
IR icon
1577
Ingersoll Rand
IR
$33.7B
$34K ﹤0.01%
934
+910
+3,792% +$29.9K
LGIH icon
1578
LGI Homes
LGIH
$1.4B
$34K ﹤0.01%
479
+21
+5% +$1.6K
NBN icon
1579
Northeast Bank
NBN
$1.14B
$34K ﹤0.01%
1,545
+1,473
+2,046% +$32.5K
NG icon
1580
NovaGold Resources
NG
$3.33B
$34K ﹤0.01%
3,825
-11,362
-75% -$78.6K
OGI
1581
Organigram Holdings
OGI
$139M
$34K ﹤0.01%
+3,525
New +$41.6K
PAR icon
1582
PAR Technology
PAR
$735M
$34K ﹤0.01%
1,112
+978
+730% +$26.8K
PENN icon
1583
PENN Entertainment
PENN
$2.71B
$34K ﹤0.01%
1,349
+497
+58% +$11K
ROG icon
1584
Rogers Corp
ROG
$2.4B
$34K ﹤0.01%
+273
New +$36.9K
SGU icon
1585
Star Group
SGU
$423M
$34K ﹤0.01%
3,560
+2,407
+209% +$22.6K
MOR
1586
DELISTED
MorphoSys AG American Depositary Shares
MOR
$34K ﹤0.01%
+947
New +$28.3K
PXD
1587
DELISTED
Pioneer Natural Resource Co.
PXD
$34K ﹤0.01%
223
-3,185
-93% -$424K
TCRR
1588
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$34K ﹤0.01%
2,371
+2,082
+720% +$32.2K
BNFT
1589
DELISTED
Benefitfocus, Inc.
BNFT
$34K ﹤0.01%
1,545
-8,244
-84% -$187K
TBIO
1590
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$34K ﹤0.01%
+4,175
New +$38.5K
PFPT
1591
DELISTED
Proofpoint, Inc.
PFPT
$34K ﹤0.01%
+300
New +$35.8K
AES icon
1592
AES
AES
$10.5B
$33K ﹤0.01%
1,680
-20,575
-92% -$368K
AGYS icon
1593
Agilysys
AGYS
$3.06B
$33K ﹤0.01%
1,305
+1,281
+5,338% +$32.4K
AMR icon
1594
Alpha Metallurgical Resources
AMR
$1.93B
$33K ﹤0.01%
3,675
+2,945
+403% +$44.8K
BHB icon
1595
Bar Harbor Bankshares
BHB
$666M
$33K ﹤0.01%
1,314
+692
+111% +$17.6K
BOH icon
1596
Bank of Hawaii
BOH
$3.13B
$33K ﹤0.01%
350
+97
+38% +$8.62K
EMN icon
1597
Eastman Chemical
EMN
$8.42B
$33K ﹤0.01%
414
-5,732
-93% -$441K
KDP icon
1598
Keurig Dr Pepper
KDP
$40.8B
$33K ﹤0.01%
1,137
-26,307
-96% -$756K
LRCX icon
1599
Lam Research
LRCX
$390B
$33K ﹤0.01%
1,120
-41,150
-97% -$1.09M
NTNX icon
1600
Nutanix
NTNX
$16.9B
$33K ﹤0.01%
1,070
+907
+556% +$26.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.